Chimerix downgraded

JPMorgan downgraded Chimerix Inc. (Nasdaq: CMRX) from an Overweight rating to a Neutral rating and slashed its price target from $62 to $12. The stock price gained 75 cents to close at $7.37.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.